1.  The Board shall adopt regulations establishing a protocol for dispensing a self-administered hormonal contraceptive, as authorized by NRS 639.28078. Those regulations must include, without limitation:

Ask a business law question, get an answer ASAP!
Thousands of highly rated, verified business lawyers.
Click here to chat with a lawyer about your rights.

(a) Requirements governing the information that must be included in a record concerning the dispensing of the self-administered hormonal contraceptive in addition to the information required by NRS 639.28078; and

(b) The amount of time that such a record must be maintained by the dispensing pharmacist or his or her employer.

2.  The Board shall adopt regulations that prescribe:

(a) A risk assessment questionnaire that must be provided to a patient who requests a self-administered hormonal contraceptive pursuant to NRS 639.28078.

(b) The information that must be provided in writing to a patient to whom a self-administered hormonal contraceptive is dispensed pursuant to NRS 639.28078, which may include, without limitation, information concerning:

(1) The importance of obtaining recommended tests and screening from the patient’s attending provider or another qualified provider of health care who specializes in women’s health;

(2) The effectiveness of long-acting, reversible contraceptives as an alternative to self-administered hormonal contraceptives;

(3) When to seek emergency medical services as a result of administering a self-administered hormonal contraceptive; and

(4) The risk of contracting a sexually transmitted infection and ways to reduce that risk.

3.  As used in this section:

(a) ’Attending provider’ means a provider of health care who provides or has provided care to the patient.

(b) ’Provider of health care’ has the meaning ascribed to it in NRS 629.031.